Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment.

Wissel, Jörg; Fheodoroff, Klemens; Hoonhorst, Maurits; Müngersdorf, Martina; Gallien, Philippe; Meier, Niklaus; Hamacher, Jürgen; Hefter, Harald; Maisonobe, Pascal; Koch, Manuel

Wissel, Jörg; Fheodoroff, Klemens; Hoonhorst, Maurits; Müngersdorf, Martina; Gallien, Philippe; Meier, Niklaus; Hamacher, Jürgen; Hefter, Harald; Maisonobe, Pascal; Koch, Manuel.

Afiliação

Wissel J; Vivantes Hospital Spandau, Berlin, Germany.
Fheodoroff K; Gailtal-Klinik, Hermagor-Pressegger See, Austria.
Hoonhorst M; Center for Rehabilitation Vogellanden, Zwolle, Netherlands.
Müngersdorf M; Neurologisches Zentrum für Bewegungsstörungen und Diagnostik, Berlin, Germany.
Gallien P; Pôle Saint Hélier, Rennes, France.
Meier N; Department of Neurology, University Hospital Bern and University of Bern, Bern, Switzerland.
Hamacher J; Praxis für Neurochirurgie, Essen, Germany.
Hefter H; Department of Neurology, University of Düsseldorf, Düsseldorf, Germany.
Maisonobe P; Ipsen Pharma, Boulogne-Billancourt, France.
Koch M; IPSEN PHARMA GmbH, Munich, Germany.

Front Neurol ; 11: 104, 2020.

Article em En | MEDLINE | ID: mdl-32184753

Palavras-chave

Dysport; abobotulinumtoxinA; botulinum toxin; spasticity; stroke

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article